Indiana University has announced a $25 million grant from the Lilly Endowment to advance an innovative recruitment strategy designed to attract top scientists to the Indiana University School of Medicine and the state more broadly.
The grant will fund the Indiana Collaborative Initiative for Talent Enrichment (INCITE), a collaboration between the IU School of Medicine and non-academic partners such as the Indiana Biosciences Research Institute, Eli Lilly and Co., Roche, Dow, Cook, BioCrossroads, IU Health, and Eskenazi Health. Working through the Indiana Clinical and Translational Sciences Institute (CTSI), the initiative also will forge partnerships with Purdue University and the University of Notre Dame.
As part of the initiative, the IU School of Medicine will look to hire biomedical scientists whose work can enhance research and education at the school as well as strengthen the economic vitality of the broader life sciences community in Indiana. To that end, members of the state’s life sciences community will serve on a scientific board that advises the school on areas of unmet need in the community and how to attract biomedical scientists whose expertise and interests are relevant to IU and INCITE partners. Collaborations will focus on research areas that build on existing strengths and opportunities for growth, including applications for genomic medicine and new treatments for cancer, Alzheimer’s disease, diabetes, and childhood diseases.
"For Indiana to continue to grow as one of our nation's leading centers for life science research and innovation, it is critical that we continue to attract the top research talent to our state," said IU president Michael A. McRobbie. "The collaboration funded by this generous grant from Lilly Endowment will further invigorate efforts by Indiana University faculty to turn their scientific breakthroughs into the types of new products, services and treatments that will have a major impact on our state's economic development and quality of life. This collaboration will also help ensure that we continue to more effectively connect the discoveries emanating from our laboratories with what our state's industry leaders need to stay and become even more competitive in today's marketplace."